The combined market cap of Belgian SME biotech companies gained top position in the European ranking. The fact that the number of qualifying companies is 2 to 3 times smaller than in other European countries confirms the intrinsic quality of the Belgian public biotech sector.
Biocartis develops and commercializes novel, broadly applicable molecular diagnostics and immunodiagnostics solutions combined with high-value clinical assay menus. The flagship product is a molecular diagnostics system comprising an instrument and disposable cartridges. Capable of detecting up to twenty-five nucleic acid biomarkers from a wide variety of sample types with truly sample-in result-out functionality, it offers fast and high quality care at the point of need.
|Product||Indications and progress||Partner|
Generaal De Wittelaan 11 B3, 2800 Mechelen, Belgium